EyeConnect International renews partnership with Leiters

EyeConnect International, a knowledge-sharing platform for ophthalmologists, has renewed its partnership with Leiters, an outsourcing provider of compounded sterile preparations and pharmacy services. 

Advertisement

Leiters is a provider of a range of ophthalmic medicines and services to ophthalmology providers, according to a Feb. 1 news release. The partnership will increase EyeConnect’s network of ophthalmologists on its online platform. 

“We are honored that Leiters recognizes the value of peer-to-peer education,” David Karcher, board member of EyeConnect International and former executive director of the American Society of Cataract and Refractive Surgery, said in the release. “We look forward to working with Leiters as we build our global online community and grow into the preferred ophthalmic knowledge-sharing platform.”

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

  • East Lansing-based Michigan Surgical Center has disclosed a data breach that may have exposed personal information, according to a July…

  • Cincinnati-based MidWest Eye Center welcomed Alec Bradley, MD, an ophthalmologist who specializes in premium cataract surgery, refractive surgery, microinvasive glaucoma…

Advertisement

Comments are closed.